NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

This study is currently recruiting participants.
Verified May 2012 by Cornerstone Health Care, PA
Sponsor:
Collaborator:
Biogen Idec
Information provided by (Responsible Party):
Cornerstone Health Care, PA
ClinicalTrials.gov Identifier:
NCT01591551
First received: April 22, 2012
Last updated: May 2, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)